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The recent development of genomic selection induces dramatic changes in the way genetic selection schemes are to be conducted.
This review describes the new context and corresponding needs for genomic based selection schemes and how reproductive
technologies can be used to meet those needs. Information brought by reproductive physiology will provide new markers and
new improved phenotypes that will increase the eﬃciency of selection schemes for reproductive traits. In this context, the value
of the reproductive techniques including assisted embryo based reproductive technologies (Multiple Ovaluation Embryo Transfer
andOvumpickupassociatedtoinvitroFertilization)isalsorevisited.Theinterestofembryotypingisdiscussed.Therecentresults
obtainedwiththisemergingtechnologywhicharecompatiblewiththeuseofthelastgenerationofchipsforgenotypeanalysismay
leadtoverypromisingapplicationsforthebreedingindustry.Thecombineduseofseveralembryobasedreproductivetechnologies
willprobablybemoreimportantinthenearfuturetosatisfytheneedsofgenomicselectionforincreasingthenumberofcandidates
and to preserve at the same time genetic variability.
1.Introduction
During recent decades, advancement in our knowledge of
reproductivephysiologyandimprovementsinembryo-based
reproductive biotechnologies have facilitated the develop-
ment of a rather complete “tool box” including reproductive
techniques used either for commercial purposes and/or in
the frame work of breeding schemes. These techniques
currently have varying degrees of eﬃciency [1]a n df o rm o s t
of them continuous improvements may be expected in the
future. Used alone or in combination, their development
is inﬂuenced in many diﬀerent ways including ethics and
general acceptance, consumer demand for speciﬁc products,
regulatory changes, and also changes related to the evolution
of breeding strategies.
The recent development of genomic selection has led to
dramatic changes in the way genetic selection schemes are
to be conducted [2, 3]. Due to the present and expected
evolution in the organisation of selection strategies and
associated requirements, the value of the various reproduc-
tive techniques used today for commercial purposes and in
genetic schemes should be revisited.
2. The New Context and Corresponding Needs
for Genomic-Based Selection Schemes
In genetic selection, the expression for a given trait is
the phenotype that integrates the eﬀect of genes and the
eﬀect of environmental factors. In the past, the eﬀect of2 Veterinary Medicine International
the genetic component was evaluated from genealogy and
by measuring performances/phenotyping of candidates or
of their progeny. Today, in association with information
issued from genealogy, genomic selection, while linking
from previous experience, the presence of genes and/or
polymorphism of those genes to performances allows to
predict the genetic value of a candidate which is revealed by
the presence of pertinent markers indicative of its genotype.
In France, Marker Assisted Selection (MAS) has been
developed since 10 years and was based initially on a limited
number of micro satellite analyses for a few Quantitative
TraitLoci(QTL).Selectionwasperformedbycombiningthis
ﬁrst generation of genomic information with conventional
indexes arising from quantitative genetics. Further develop-
ments followed the work of Meuwissen et al. [4] who have
shownthatitwaspossibletopredictthetotalgeneticvalueof
animalsor plants by usinggenome-widedense marker maps.
The progress of the knowledge of the bovine genome and
of DNA analyses has made dense marker maps available in
this species and the position of markers in relation to genes
of interest has been reﬁned. This allows animal breeding
companies to use today sets of thousands of genetic markers
to select animals [5–10]. The development of genomic
techniques will probably make available the use of the
completegenomeinformationforselectionpurposesinafew
years [11]. Diﬀerent types of chips based on the use of Single
Nucleotide Polymorphism (SNP, i.e., a single base diﬀerence
on the DNA between individuals or groups of individuals)
are available and can be used to achieve diﬀerent objectives.
The bovine 50K SNP chip has become the standard tool for
breeding industries in dairy cattle, and a higher density chip
800K SNP is also available to screen for more genes and for a
deeper implementation of genomic selection. A smaller and
less expensive 3K SNP chip is now also available to screen
large populations [11]. Today, a lot of progress has been
achieved for the Holstein breed and in other major dairy
breeds (such as the Montbeliarde and Normande breeds) in
which all the characters previously evaluated using classical
selection by quantitative genetics can now be evaluated from
genomic information [12]. For instance, in France, recent
developments allow this evaluation to be made by using
several hundreds of markers per character instead of 30QTL
per characters as in the previous MAS evaluation [6]. Due
to those technical improvements, application to small breeds
can now be expected [5]a n de ﬀorts should be made to
alsogetappropriatephenotypicinformationforthosebreeds
which have not been studied as intensively as the Holstein
breed and other major dairy breeds.
In parallel with those technological changes, attempts
have been made in diﬀerent countries to reinforce the
value of the genomic information by including more and
more animals in the evaluation and selection process [5, 7].
Consequently, more reliable estimates can be obtained for
the desired traits while genetic variability is better preserved.
Candidateswillhavetobeproducedfromparentsofdiﬀerent
pedigree’s (maximum of families within a breed) and at
the same time breeding should be organised in a way
to maximize the variability of the next generation. The
potential advantages of genomic selection programmes run
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Figure 1: Accuracy of fertility Estimated Breeding Value of young
animals (<2 years of age) and after progeny test without molecular
information, and of animals with MAS information (MAS 2009,
MAS 2010) obtained before 2 years of age [12, 14].
on these principles have been shown recently by Monte-
Carlo simulations on full-size breeding schemes [13]. This
work demonstrated that by multiplying the number of
candidates by 3 it was possible at the same time to increase
genetic progress dramatically (+80% when compared to the
classical breeding scheme) while decreasing inbreeding rate
(−23%).
Due to its costs and to the fact that the genetic value
of a given future sire is known with enough precision
from genomic analyses, the need for progeny testing will be
considerably reduced or even removed [3]. For some traits,
such as those related to fertility, the precision associated with
genomic indexes is or will be much better than with classical
selection [12, 14]( Figure 1).
Questions are raised about the need to keep a common
reference basis in diﬀerent populations to optimize the eval-
uation process and evaluate the changes induced by genomic
selection. This is illustrated by the recent agreement in the
consortium “Eurogenomics”, a group of breeding companies
from France, The Netherlands, Germany, Denmark, Finland,
and Sweden to gather and share the genomic information for
evaluationofbreedingvaluesfromacommonreferencebasis
including 16 000 Holstein sires [15].
Research is made also on computational methodologies
to deﬁne the best way to analyse and use the huge quantity
of information arising from genomic analyses of a very large
number of animals [5].
For all traits of interest, these changes highlight the
importanceofthephenotypicinformationthatmustbeuniﬁed
from large number of animals in the reference base and
which becomes one of the main bottlenecks in the process.
3.How CanReproductivePhysiology and
ReproductiveTechniquesHelp toMeet the
Needs of Genomic Selection and Commercial
Production within this Context?
3.1. Reproductive Physiology. In an attempt to improve
numerous traits by genomic selection, knowledge of the
relationships between genome information and phenotypic
criteria is of crucial importance. Following initial studiesVeterinary Medicine International 3
[16–19], the development of microarrays (dedicated or
generic) helped to characterise the relationships between
genotype and phenotype. More recently, high throughput
technologies for DNA sequencing and RNA analysis have
become more and more aﬀordable and are now currently
used in research programs aiming to study relationships
between genotype and phenotype and gene expression.
With such objectives, phenotyping (animal models, precise
criteria, and methods) becomes the main bottleneck to
achieve this goal. As a consequence, there will be a need for
research aiming to phenotype new critical traits and/or to
improve the precision of the phenotypes for existing traits.
For instance, for reproductive traits, it is possible, by using
measurements of progesterone and pregnancy associated
proteins, to characterise relatively well pregnancy failure
[20]. This has been used in a genomic programme aiming to
screen (from a large database) for the existence of candidate
mutations that may explain diﬀerences in fertility between
progeny groups [21]. However, for such an approach, meth-
odsallowingonetodistinguishfertilizationfailurefromearly
embryonic mortality are still lacking and such developments
would be most valuable to ﬁnd new markers of fertility.
Similarly,alotofinformationandnewphysiologicalmarkers
for fertility may be derived from investigations made to
better characterize reproductive function. For instance, due
to the strong relationships existing between oocyte growth
and maturation and subsequent embryonic development
[22], programs aiming to study links between follicular
growth, oocyte quality, and the presence of genomic mark-
ers by using proteomics, lipidomics, and metabolomics
may be particularly appropriate to ﬁnd new markers for
fertility [23].
3.2. Use of Embryo-Based Biotechnologies. One of the most
important features of the new selection procedures will be
to considerably increase the number of candidates submitted
to genomic selection to maximize the chances of getting
interesting individuals that will be positively evaluated for
a large number of traits. As mentioned before, this will
allow an increase in the selection pressure for those traits.
Also, it will be possible to use bulls for AI at a younger
age, thereby lowering the generation interval. Finally, the
use of groups of bulls with a favourable genomic index will
improve the precision of indexes when compared to the use
of a very limited number of older sires as was the case in
the past. This may be also favourable to genetic variability
if adequate and wise breeding schemes are implemented;
otherwise shortening the generation interval may also lead
to an increased inbreeding rate.
The way to produce these large numbers of animals
becomes critical. In this context, AI alone may be inadequate
to generate suﬃcient animals in a given period of time
and the eﬃciency of MOET and OPU-IVP looks more and
more critical to produce these large numbers of animals
to be genotyped. With these “intensive” embryo-based
reproductive techniques, it is relatively easy to increase the
number of candidates by increasing the number of ﬂushes
in MOET schemes. When compared to MOET, the number
o fe m b r y o sp r o d u c e di nag i v e np e r i o do ft i m ec a ne v e nb e
multiplied by 2 or 3 [1, 24]b yt h eu s eo fr e p e a t e dO P U -
IVF sessions leading to the production of approximately
70calves/donor and per year. Females of various origins can
be collected to preserve genetic variability and this technique
presents additional advantage if diﬀerent bulls are used for
diﬀerent OPU sessions or even within a session [1, 24].
A lot of research has been done to improve in vitro
culture systems to attempt to mimic as much as possible the
oviduct ﬂuid environment. Synthetic Oviduct Fluid (SOF)
basedculturesystemsarethemostcommonlyusedtodayand
overall development rates to the blastocyst stage of 30–40%
a r ea c h i e v e db ym o s tt e a m s .T h i si sp r o b a b l ya sm u c ha sc a n
beexpectedgiventheheterogeneityinfolliclestypicallyused.
The eﬀect of a previous superovulation on fertilisation and
subsequent embryonic development is still controversial as
some authors reported detrimental eﬀects [25, 26]w h e r e a s
other studies show similar embryonic development rates
under those 2 conditions [1]. Irrespective of the type of
treatment of the donor female and type of culture system,
it has been shown very clearly from most studies that there
is a signiﬁcant decrease in embryo production when oocytes
are matured in vitro in standard medium compared to in
vivo conditions [25–29]. This emphasizes the roles of the
ﬁnal steps of oocyte growth and maturation in subsequent
embryo development which have also been illustrated by
epidemiological studies made under in vivo conditions
showing relationships between certain factors inﬂuencing
these steps and embryonic mortality [22]. There is probably
a lot of progress that can be achieved in in vivo and in
vitroembryoproductionbyoptimizingtheconditionsunder
which the oocytes are growing within follicles in donor
females. Handling at the time of collection and thereafter
as well as in vitro maturation are also critical steps to
be optimized since dramatic metabolic changes occur very
quickly after oocyte recovery [30].
Despite the above-mentioned limitations and potential
margins for progress, the work that has been done in the past
15 years to improve oocyte collection and in vitro embryo
production systems has made those systems viable and
practically useful by the most advanced breeding companies
to produce more embryos in their genetic schemes [24, 31].
However, (i) to mismanage the use of these techniques may
lead to increase inbreeding signiﬁcantly especially if bull
dams are overexploited (Colleau 2010, personal communi-
cation) and (ii) due to the new requirements in relation
to the implementation of genomic selection (especially
those related to the increase in the number of candidates),
additional strong limitations exist for giving birth to a very
large number of calves that would be genotyped after birth.
Eﬀectively, one of the main bottlenecks experienced by
breedingorganisationsworkinginEuropewithdairycattleis
the limited availability of femalerecipients. This is reinforced
by the fact that, due to lower pregnancy rates when using
cows instead of heifers as recipients, the eﬃciency of embryo
transferismuchloweriftheheifersareusedmainlyasdonors
and not as recipients [1]. In addition to this, high costs will
be induced by the transfer of a very large number of embryos
into recipients that must be maintained pregnant until birth
of progeny and the economic potential of the nonselected4 Veterinary Medicine International
calves will be low. When producing these candidate animals
on farm, the amount of ﬁeld work in relation to embryo
transfer and in vitro production will be even greater than
today and will generate high logistical costs. Finally, this
process may increase the contractual cost with individual
farmers especially due to the potential existence of very
interesting candidates identiﬁed by genomics.
For these reasons, genotyping the embryos and selecting
them before transfer appears to be an attractive scenario to
maximize the chances to ﬁnding interesting individuals for
multiple traits while transferring a “reasonable” number of
embryos.
3.3.EmbryoTyping. Theinterestofembryotypingforbreed-
ing companies was discussed even before the emergence of
the new techniques for genomic selection that includes today
thousands of markers [24]. As soon as MAS based on a
limited number of micro satellites could be used, advantages
were found due to its potential value for screening the
embryo for several traits. At the same time, embryo sexing
could be used at a very low cost during the process of
genomic analyses. Doing typing and selection early in life
was also expected to be a solution to shorten the generation
interval and to limit the costs of producing the high number
of calves and associated costs of the existing progeny testing
to achieve multicharacter selection. Today the potential
advantages of combining intensive embryo production and
genotyping are even higher.
Results reported initially in the literature for ruminants
[32, 33] were based on the typing for a limited number of
markers. Peippo et al. [32] have shown that it was possible to
genotype embryonic biopsies for a limited number of micro
satellites and to get subsequent pregnancies after transfer of
thecorresponding biopsied bovine embryos.Similarly, inthe
goat, Guignot et al. [33] reported the possible use of embryo
genotyping for a very limited set of markers to screen for
sensitivity to scrapie combined with sex determination. The
most recent published results emerged from the programme
“TYPAGENAE”inwhichtheeﬃciencyofembryotypingwas
tested from a set of 45micro satellites corresponding to the
ﬁrst generation of MAS [34–36].
In a ﬁrst step, in vitro produced embryos were used to
assess the accuracy and repeatability of embryo-based geno-
typing. Day 6 embryos were biopsied and each blastomere
from the biopsy was submitted to embryonic cloning to
reconstitute full blastocysts [37]. A mean of 2 full blastocysts
were obtained from cloning blastomeres and more than 95%
of the embryos survived in culture following biopsy. The
results of typing obtained from the reconstituted blastocyst
and the donor embryo were subsequently compared from
a total of 41 samples. The proportion of successfully typed
samples was >90%. The typing of the cloned embryos
corresponded all the time to the typing of the original
embryos and genotypes were fully compatible with the
genotypes of the parents. The error rate, when considering
diﬀerences between the diﬀerent types of samples, was 3%
and all errors were due to the lack of identiﬁcation of one of
the alleles (drop-out).
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Figure 2: Eﬀect of the number of cells of the biopsy on the
percentage of detection of microsatellites (markers typed) and on
the percentage of typing errors [2, 36].
From a second series of experiments, the typing results
between biopsies of 10–20 cells performed at the blastocyst
stage and the rest of the embryo were compared. Whole
Genome Ampliﬁcation (WGA) was applied on cell extracts
from the biopsy before typing. From 60 samples, 95% were
genotyped and a similar rate of allelic drop out was observed
when compared to analyses made from full embryos (2-3%).
Another set of 40 samples was used to evaluate the minimum
numberofcellstobebiopsiedbeforepreampliﬁcation.WGA
was performed on all samples and allowed genotyping in
98% of cases with <10% drop out rates from biopsies of 8–
10cells.Thisratewasmuchhigherinbiopsiescontainingless
than 5 cells [2, 36]( Figure 2).
From a further series, the correspondence between
resultsofembryotypingandoftypingcarriedoutinfoetuses
and young calves was 100% (13 couples embryo/calf or
foetus with the same typing results). Those ﬁrst results
obtained with biopsies derived from in vivo or in vitro
embryos produced at the research station and biopsies
performed in a central laboratory were completed by a set
of results where biopsies were made on farm following the
collection of in vivo produced embryos [34]. Typing was
made by using the usual set of 45micro satellites markers
which was completed by the analysis of a complementary set
of13Single Nucleotide Polymorphism(SNP)markers.From
57 biopsied embryos, the total detection rate was higher for
SNPs than for micro satellites (70.2% versus 31.6%; P<. 01).
The detection rates of the markers were not signiﬁcantly
aﬀected by embryo stage, biopsy size, or sex of the embryo.
However, from those series of biopsies made under farm
conditions by diﬀerent embryo transfer teams, the propor-
tions of markers detected were much lower than when the
biopsies were prepared in the laboratory and immediately
followedbywholegenomeampliﬁcation.Inaddition,despite
the amount of preampliﬁed DNA was found suﬃcient
in all samples, the percentage of markers detected varied
considerablybetweenteamssuggestingthattheconditionsof
preparation and/or transportation may aﬀect the quality of
the DNA to be preampliﬁed and consequently the eﬃciencyVeterinary Medicine International 5
Table 1: Pregnancy rates following transfer of biopsied embryos on
farms in diﬀerent French programs since 2005.
Author Year of
transfer
Type of
embryos N Pregnancy
rate
P o n s a r te ta l .
2008 [39]
2002–2007 Fresh 1333 63.3%
Frozen 669 52.0%
Lacaze et al.
2008 [38]
2005–2008
(Aubrac) Frozen 132 55.3%
of the system. To avoid this, conventional freezing of the
biopsy cells should be recommended.
Additional experiments were carried out to evaluate
and compare the developmental ability of biopsied embryos
after in vitro culture and the pregnancy rates following
transfer of in vivo produced embryos previously biopsied
and frozen. Embryo survival following the biopsy of in
vitro produced embryos was not diﬀerent from the rate
observed for nonbiopsied embryos from the same series of
production that were used as controls (58/64 versus 18/20;
90%). From subsequent series, the embryonic development
in vitro following biopsy of in vivo and in vitro produced
embryos was not diﬀerent (62/70; 89% versus 41/44; 93.2%).
These results indicate that the eﬀects of the biopsy by itself
on subsequent embryonic development are very limited
irrespective of the system used to produce the embryos.
Pregnancy rates following the transfer on farm of fresh
biopsied in vivo produced grade 1 and 2 (IETS classiﬁcation)
embryos were over 60% [38, 39]( Table 1). Ponsart et al. [39]
reported pregnancy rates of 50% or more following transfer
of frozen biopsied embryos on farm and this percentage
was close to 60 when transfers were made under the more
controlled conditions of a research station (54/90; frozen).
In addition, from more recent series in station, it has
been shown that grade 3 embryos may be used as well as
pregnancyratesfollowingtransferofthosewerenot diﬀerent
when compared to results obtained with grades 1 and 2 [40].
When considering these results, the typing from biopsied
in vivo produced embryos looks realistic as the development
rates and pregnancy rates following transfer of biopsied
a n df r o z e ne m b r y o sd on o ts e e mt ob em u c ha ﬀected
by the biopsy procedure itself. In addition, those results
show that most embryos, even grade 3, could probably be
kept in the process and this would allow most of them to
be genotyped. Despite the fact that good pregnancy rates
have been reported with frozen in vitro produced embryos
in many countries [1], improvements are probably still
necessary for those, because of the selection usually applied
before and after freezing by most teams and lack of data on
pregnancy rates following direct transfer of large numbers of
biopsied and frozen in vitro produced embryos.
Calculationshavebeenperformedtoestimatethegenetic
and economic advantages of using embryo typing in associa-
tion with MOET when compared to the use of conventional
embryo transfer alone. In a ﬁrst study, simulations based
on the use of the ﬁrst generation of MAS markers were
made from real series of observations obtained from females
included as donors in genetic schemes and performances of
their sons evaluated at various ages [41]. Those simulations
have shown that the use of embryo typing is associated with
very signiﬁcant advantages at the time of early evaluations
(up to 1 year of age) that disappears at the time of ﬁnal
evaluation. This indicates that when using this ﬁrst genera-
tion of typing method (limited number of micro satellites),
the embryo typing scenario suﬀered both from the lack
of precision of the genetic information from young donor
females and from the lack of precision of the genotyping
evaluation which was used to select those embryos early in
life. These defaults are much less important now and almost
disappear today (i) due to the better knowledge associated
withyoung parents facilitated bythe accumulationof genetic
information through generations and (ii) it will become
completely negligible/nonexistent with the gain of precision
obtained from the use of the 54k SNP chip or from future
WholeGenomeEvaluation.Othertypesofsimulationsbased
on the costs induced by diﬀerent scenarios to produce the
same number of bulls of the same genetic value revealed that
substantial gains can be achieved with the help of embryo
typing if the whole set of reproductive techniques is well
controlled.
Additional economic and genetic simulations should be
performed in this new context of using high density markers
chips to precisely evaluate the costs and advantages for
the genetic schemes of such procedures based on embryo
typing. Limitations may be encountered in relation to the
technical feasibility of using ampliﬁed DNA together with
the latest generation of high density marker chips. However,
preliminary studies from limited numbers of biopsies and
typing have shown that the use of preampliﬁed DNA is
compatible with the typing from those chips (Lebourhis
et al. 2010, unpublished). This must be veriﬁed with the
next generation of chips that will include 600000 markers.
Cost eﬃciency of the whole system must be veriﬁed also
by simulations made from diﬀerent scenarios. If needed,
alternatives may be found by using other types of chips fully
compatible with the analysis of preampliﬁed DNA allowing
a prescreening of the embryos at a very low cost before
performing full genotyping in calves.
3.4. Other Reproductive Techniques. To a certain extent,
sperm sexing can help to limit the number of embryos to be
produced for this purpose and may be used in combination
with in vitro fertilisation and in vitro production (IVF-IVP)
procedures. Use of semen sexing in association with IVF-
IVP may also avoid some of the present limitations of the
use of semen sexing in selection schemes in relation to the
high number of sperm that must be discarded and the large
individual variation associated with the sexing process by
ﬂow cytometry [42].
Finally, considering the need to maximize genetic vari-
ability and due to strong limitations in reproductive eﬃ-
ciency, cloning is unlikely, at least at present, to represent
a useful tool in the framework of selection schemes. How-
ever, besides selection schemes driven by breeding associa-
tions/companies, individual farmers, that may get access to
genomic selection, may be interested in the duplication of
their best animals with the help of cloning for commercial6 Veterinary Medicine International
purposes in countries allowing the use of this process.
Some applications may result from the use of transgenesis
associated with cloning; however, such technical options
especially in the EU context will face strong limitations in
relation to ethics, public concern, and political attitude that
will probably limit their use to types of production diﬀerent
from agronomics.
4. Impact of Genomic Selection on
the Use of Reproductive Techniques and
More Speciﬁcally ART
4.1. Genetic Schemes. Artiﬁcial Insemination (AI), Multiple
Ovulation and Embryo Transfer (MOET) and/or, depending
on legislation in individual EU countries, Ovum Pick Up
associatedwithinvitroEmbryoProduction(OPU-IVP)have
already been used in the past to generate the future sires to
be widely used following selection through highly eﬀective
but very costly progeny testing programmes. The changes
in breeding strategies and use of reproductive techniques
associated with the needs of genomic selection are on the
way. They result from the organisation of selection schemes
which are already today completely diﬀerent. As shown
before, eﬃciency of embryo transfer, OPU and IVF, will be
critical and these techniques will be probably more used
than in the past to increase the number of candidates.
There is a large phenotypic variability between individual
females for in vivo and in vitro productions [43, 44]. Taking
into account the genetic index of donor females in OPU-
IVP production may also be used to optimize the results
[44]. On top of this, the potential value of the genotyped
animals will probably lead breeding associations/companies
to adopt strategies allowing them to control the production
of genome-selected animals. This will lead them to reinforce
theuseofembryo-basedreproductivetechniquesMOETand
IVPinnucleusherdstogivebirthtopreviously(pre)selected
animals within a given structure/company and not on farm.
In this context, the success of embryo typing before transfer
maybemoreandmorecriticalforthebreedingorganisations
and some of the companies involved in Eurogenomics have
already started to include embryo typing in their selection
process.
4.2. Commercial Activity. As soon as genotyping will be
extended, farmers will have access to the corresponding
information in females. This will probably induce a strong
rise in the demand for ET and even OPU and IVF from
farmers wishing to optimize the value of their best females
within their herds and/or for commercial purposes.
5. Conclusion
In the new context of genomic selection, there is still a
lot of work for the reproductive physiologist to study gene
expression and identify markers and networks of genes
associated with fertility. As far as selection for fertility is
concerned, more precise phenotyping is needed for partic-
ular reproductive events and more especially for precocity of
reproductive traits that has not been well characterized so
far. More generally, for all production traits and functional
traits, in the present context showing very impressive
improvements induced by the intensive use of MAS, it is
likelythattheuseofasetofintensivereproductivetechniques
together with embryo typing will bring very signiﬁcant
advantages to breeding organisations capable of monitoring
all those techniques with eﬃciency. However, strategies must
be developed to use all these techniques in such a way that
they contribute to maintain genetic variability. It is clear that
the emergence of the new methods for genomic selection
makes all improvements related to embryo production in
vivo or in vitro and associated techniques very attractive
for breeding organisations and companies willing to exploit
as much as possible the advantages of genomic selection.
T h e r ew i l lp r o b a b l ya l s ob es o m ec h a n g e si nr e l a t i o nt o
commercial activity due to valuable genomic information
becoming available in females that may lead individual
farmers/companies to make a larger use of semen sexing and
embryo related technologies.
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